Spruce Biosciences

Spruce Biosciences

Spruce Biosciences

Spruce Biosciences is a clinical-stage biopharmaceutical focused on developing new treatments for rare endocrine disorders.
Founded
2014
Raised
$88M
Follow us
Alexa global traffic share
Latest funding
$88,000,000
Venture capital (Series B) - 2020
Aisling Capital Rock Springs Capital Omega Funds +5
Team Size
1–10
Employees
$88,000,000 Venture capital (Series B)
FinSMEs , Xconomy

Spruce Biosciences Raises $88M in Series B Financing